1-pyrrolidineethanol hydrochloric acid | 30727-31-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 1-pyrrolidineethanol hydrochloric acid
• 英文别名: 2-(N-pyrrolidino)ethanol hydrochloride；2-pyrrolidino-ethanol; hydrochloride；2-Pyrrolidino-aethanol; Hydrochlorid；pyrrolidin-1-yl-ethanol hydrochloride；2-pyrrolidin-1-ylethanol;hydrochloride
• CAS: 30727-31-2
• 化学式: C₆H₁₃NO*ClH
• 分子量: 151.636
• InChiKey: YSUZHUSIBQEHEH-UHFFFAOYSA-N

物化性质

• 熔点：
  88-90 °C

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  23.5
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  1-pyrrolidineethanol hydrochloric acid 、 LY303366 在 盐酸 作用下， 以 二甲基亚砜 为溶剂， 反应 48.0h， 以17%的产率得到O-[2-(N-pyrrolidino)ethyl] 303366
  参考文献：
  名称：

  The Synthesis and Antifungal Activity of Nitrogen Containing Hemiaminal Ethers of LY303366.

  摘要：

  DOI：

  10.7164/antibiotics.51.239

文献信息

• [EN] KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA KINASE
  申请人：LILLY CO ELI

  公开号：WO2005080380A1

  公开（公告）日：2005-09-01

  ABSTRACT The present invention provides kinase inhibitors of Formula I: .

  摘要 本发明提供了化合物I的激酶抑制剂。
• [EN] BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE<br/>[FR] BENZIMIDAZOLES ET BENZOTHIAZOLES UTILISES COMME INHIBITEURS DE LA MAP KINASE
  申请人：LILLY CO ELI

  公开号：WO2004014900A1

  公开（公告）日：2004-02-19

  The present invention provides kinase inhibitors of Formula I: wherein W represents inter alia imidazol, oxazol, pyrazol, thiazol as triazol, which are substituted by phenyl or thienyl. The disclosed compounds inhibit p-38 kinase and are useful in the treatment of metastasis or rheumatoid arthritis.

  本发明提供了一种化合物I的激酶抑制剂：其中W代表咪唑、噁唑、吡唑、噻唑或三唑等，这些化合物被苯基或噻吩基取代。所公开的化合物抑制p-38激酶，在转移或类风湿性关节炎的治疗中很有用。
• Benzimidazoles and benzothiazoles as inhibitors of map kinase
  申请人：Bonjouklian Rosanne

  公开号：US20050272791A1

  公开（公告）日：2005-12-08

  The present invention provides kinase inhibitors of Formula I: wherein W represents inter alia imidazol, oxazol, pyrazol, thiazol as triazol, which are substituted by phenyl or thienyl. The disclosed compounds inhibit p-38 kinase and are useful in the treatment of metastasis or rheumatoid arthritis.

  本发明提供了式I的激酶抑制剂：其中W代表咪唑、噁唑、吡唑、噻唑或三唑等，它们被苯基或噻吩基取代。所披露的化合物抑制p-38激酶，在治疗转移或类风湿性关节炎方面有用。
• Kinase Inhibitors
  申请人：Bonjouklian Rosanne

  公开号：US20080227839A1

  公开（公告）日：2008-09-18

  The present invention provides kinase inhibitors of Formula I:

  本发明提供了化合物I的激酶抑制剂：
• Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 4. Effect of various side-chain substituents on therapeutic activity against anticholinesterase intoxication
  作者：Dane A. Goff、Gary A. Koolpe、Andrew B. Kelson、Huynh M. Vu、Dorris L. Taylor、Clifford D. Bedford、Ralph N. Harris、H. A. Mussalam、Irwin Koplovitz

  DOI：10.1021/jm00108a019

  日期：1991.4

  A series of quaternary salt derivatives of 2-[(hydroxyimino)methyl]-1-methylimidazole incorporating various side chains bearing ether, silyl, nitrile, ester, halogen, nitro, sulfone, amino, or aminosulfonyl substituents was prepared and evaluated in vivo for the treatment of anticholinesterase intoxication. Test results in the mouse revealed that the type and location of the side-chain substituent both have a significant influence on the toxicity and antidotal effectiveness of the compounds. Some of the more active examples represent the most potent therapeutics to date against intoxication by the powerful cholinesterase inhibitors soman and tabun. Significantly, the antidotal effectiveness of the compounds was not dependent on the inhibiting agent nor was there any correlation between in vivo efficacy and in vitro reactivation of ethyl (4-nitrophenyl)methylphosphonate inhibited human acetylcholinesterase. These observations suggested that the main mode of antidotal protection by the compounds is something other than enzyme reactivation.